An impurity of Felypressin. Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
CAT No: 10-101-193
Synonyms/Alias:[4-glutamic acid]felypressin;3-((4R,7S,10S,13S,16S,19R)-19-amino-4-((S)-2-(((S)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-7-(2-amino-2-oxoethyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-10-yl)propanoic acid
Felypressin Impurity F is a specialized carbohydrate compound often encountered during the synthesis and analysis of felypressin, a vasopressin analog used in various biochemical and pharmaceutical research contexts. Characterized by its unique structural features, Felypressin Impurity F is distinguished by its relevance in quality control and analytical characterization of peptide-based products. The presence of such impurities is a common occurrence in peptide manufacturing, and their identification plays a pivotal role in ensuring the consistency, stability, and performance of the final product. As research and industrial laboratories continue to expand the scope of peptide therapeutics and diagnostic tools, the need to understand, detect, and quantify related impurities like Felypressin Impurity F has become increasingly significant.
Analytical Method Development: Felypressin Impurity F is frequently employed as a reference standard or analytical target during the development and validation of chromatographic and spectrometric methods. Its well-characterized structure allows researchers to optimize separation techniques such as HPLC and LC-MS, facilitating the precise detection and quantification of impurities in complex peptide mixtures. By incorporating it into analytical workflows, laboratories can enhance method sensitivity, specificity, and reproducibility, thereby supporting rigorous quality assessments of peptide products.
Peptide Synthesis Process Optimization: In the context of peptide synthesis, the presence and behavior of Felypressin Impurity F provide valuable insights into reaction pathways, side reactions, and the overall efficiency of synthetic protocols. Monitoring this impurity enables chemists to identify critical steps where by-products are generated, allowing for targeted process adjustments that minimize unwanted compounds. This approach not only improves the yield and purity of the target peptide but also informs the design of more robust and scalable synthetic methodologies.
Stability Studies and Degradation Profiling: The inclusion of Felypressin Impurity F in stability studies helps researchers assess the degradation pathways of felypressin and related analogs under various environmental conditions. By tracking the formation and accumulation of this impurity over time, scientists can better understand the factors influencing peptide stability, such as temperature, pH, and exposure to light or oxidants. These insights are crucial for developing optimized storage conditions and packaging solutions, ultimately extending the shelf life and reliability of peptide-based research reagents.
Reference Material for Impurity Profiling: As a well-defined entity, Felypressin Impurity F serves as a critical reference material in impurity profiling studies. Its availability allows laboratories to establish accurate calibration curves, perform system suitability tests, and verify the performance of analytical instruments. By comparing the chromatographic or spectrometric signatures of unknown samples to those of known impurities, researchers can confidently identify and quantify trace components, ensuring the thorough characterization of peptide preparations.
Research on Structure-Activity Relationships: The study of Felypressin Impurity F contributes to a deeper understanding of structure-activity relationships among vasopressin analogs and their derivatives. By investigating how subtle structural variations influence biological activity, binding affinity, and physicochemical properties, scientists can design improved analogs with enhanced selectivity and performance. Such knowledge supports the ongoing development of novel peptides for research applications, expanding the toolkit available for probing complex biological systems and advancing peptide science.
2. Myotropic activity of allatostatins in tenebrionid beetles
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More